jun-Bは,c-jun-Bの変換およびトランス活性化活動を抑制し,c-fosは,c-junの変換およびトランス活性化活動を刺激する
Cell
|December 22, 1989
まとめ
人間のjun-B遺伝子は,細胞変異とAP-1トランス活性化に関与していますが,c-jun.を否定的に調節します. この相互作用は悪性変異と遺伝子発現に影響を与え,複雑な調節機構を明らかにします.
科学分野:
- 分子生物学は分子生物学である.
- 腫瘍学 腫瘍学
- 遺伝子規制 遺伝子規制
背景:
- c-JunとJun-Bを含むトランスクリプション因子のJunファミリーは,遺伝子発現の重要な調節因子です.
- これらの要因は,増殖,分化,アポトーシスなどの細胞プロセスにおいて重要な役割を果たします.
- ジュンタンパク質の調節不全は,様々な癌に絡み合っており,悪性変異におけるその重要性を強調しています.
研究 の 目的:
- 人間のJun-B遺伝子をクローンし,特徴づけること.
- jun-B.の変換およびトランス活性化活動を調査する.
- 細胞変異と遺伝子調節におけるjun-Bとc-junの相互作用を解明する.
主な方法:
- 人間のJun-B.の遺伝子クローニングとシーケンシング
- 原始ラット胚細胞とラット-1A細胞を用いた細胞変容アッセイ.
- c-Ha-ras と他の転写因子 (c-jun, c-fos) のような腫瘍遺伝子の共伝染実験.
- F9テラトカルシノーマ細胞におけるAP-1トランス活性化活動の分析.
主要な成果:
- Jun-Bは, ras. と協力する際に,c-junと比較して,より低い変換および不死の効力を発揮します.
- Jun-Bは単独では,c-jun.とは異なり,ラット-1A細胞を変容させない.
- c-junとjun-Bの共同発現は,変換の減少とAP-1のトランス活性化につながり,負の調節を示唆します.
- このマイナスの相互作用は,TPA (12-O-テトラデカノイルホルボル-13-アセテート) によって部分的に逆転します.
結論:
- Jun-Bとc-junはどちらもAP-1のトランス活性化と悪性変異に寄与する.
- jun-Bとc-junの相互作用には,負の規制メカニズムが含まれています.
- これらのジュンタンパク質の相互作用を理解することは,腫瘍学的経路を解読し,標的治療を開発するために重要です.
関連する概念動画
Co-activators and Co-repressors
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
Eukaryotic Transcription Inhibitors
Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
General Transcription Factors
Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Co-activators and Co-repressors
Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
MAPK Signaling Cascades
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
TGF - β Signaling Pathway
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...


